Precision medicine in South Africa: apply for funding
UK businesses can apply for a share of £1.5 million to work with South African partners on non-communicable diseases and child health.
Innovate UK has up to £1.5 million to invest in business projects to develop affordable gene-based diagnostics for non-communicable diseases and child health in South Africa.
The competition aims to encourage innovative partnerships between the UK and South Africa. It is co-funded by Innovate UK and the South African Medical Research Council (SAMRC).
Projects should seek to develop affordable gene-based diagnostic solutions and targeted treatments for one or more of the following health challenges in South Africa:
- cardiovascular disease
- child mortality
The competition is administered by the Newton Fund. Projects must demonstrate how they can have a positive social, economic and/or environmental impact on the wider South African population.
The Newton Fund is part of the UK’s official development assistance. It uses science and innovation partnerships to promote economic development and social welfare of partner countries.
- the competition is open, and the registration deadline is midday 10 May 2017
- projects must be led by a UK business working with at least one South African business or research organisation
- we expect projects to range in size from £300,000 to £500,000 on the UK side and to last up to 36 months
- UK businesses could attract up to 70% of their project costs
- South African partners will be funded by SAMRC
- a briefing event for potential applicants takes place on 3 February 2017